- Home
- TNON vs FOXO Comparison
TNON vs FOXO Comparison
Compare TNON & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- FOXO
- Stock Information
- Founded
- TNON 2012
- FOXO 2019
- Country
- TNON United States
- FOXO United States
- Employees
- TNON N/A
- FOXO N/A
- Industry
- TNON Medical Specialities
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- TNON Health Care
- FOXO Technology
- Exchange
- TNON Nasdaq
- FOXO Nasdaq
- Market Cap
- TNON 3.2M
- FOXO N/A
- IPO Year
- TNON 2022
- FOXO N/A
- Fundamental
- Price
- TNON $1.20
- FOXO $0.12
- Analyst Decision
- TNON Strong Buy
- FOXO
- Analyst Count
- TNON 2
- FOXO 0
- Target Price
- TNON $16.00
- FOXO N/A
- AVG Volume (30 Days)
- TNON 21.4M
- FOXO 2.0M
- Earning Date
- TNON 05-13-2025
- FOXO 11-19-2024
- Dividend Yield
- TNON N/A
- FOXO N/A
- EPS Growth
- TNON N/A
- FOXO N/A
- EPS
- TNON N/A
- FOXO N/A
- Revenue
- TNON $3,277,000.00
- FOXO $1,341,000.00
- Revenue This Year
- TNON $118.16
- FOXO N/A
- Revenue Next Year
- TNON $7.40
- FOXO N/A
- P/E Ratio
- TNON N/A
- FOXO N/A
- Revenue Growth
- TNON 11.92
- FOXO 196.03
- 52 Week Low
- TNON $0.91
- FOXO $0.11
- 52 Week High
- TNON $15.79
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- TNON 44.83
- FOXO 33.25
- Support Level
- TNON $2.01
- FOXO $0.11
- Resistance Level
- TNON $3.26
- FOXO $0.14
- Average True Range (ATR)
- TNON 0.51
- FOXO 0.01
- MACD
- TNON -0.06
- FOXO 0.00
- Stochastic Oscillator
- TNON 5.87
- FOXO 18.70
Stock Price Comparison Chart: TNON vs FOXO
■ TNON
■ FOXO
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Share on Social Networks:
0